Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Hua Bai, Wen-Hui Wang, Fan-Fan Zhou, Dan Yang & Rui-Jun Li. (2024) Feasibility and Tolerability of Anlotinib Plus PD-1 Blockades for Patients with Treatment-Refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study. Cancer Management and Research 16, pages 73-86.
Read now
Read now
Zhengyang Fei, Mingjun Rui, Yingcheng Wang & Aixia Ma. (2023) Cost-effectiveness of anlotinib vs. pembrolizumab and nivolumab as third-line treatment in recurrent small cell lung cancer in China. Expert Review of Pharmacoeconomics & Outcomes Research 23:1, pages 79-87.
Read now
Read now
Meng Jia, Jiang-Kun Jia, Jian Xu & Huan-Zhou Xue. (2022) Feasibility and Tolerability of Lenvatinib, Plus PD-1 Blockades for Patients with Unresectable Hepatocellular Carcinoma: A Retrospective Exploratory Study. Cancer Management and Research 14, pages 2625-2638.
Read now
Read now
Hao-Ran Zheng, Ai-Min Jiang, Huan Gao, Na Liu, Xiao-Qiang Zheng, Xiao Fu, Rui Zhang, Zhi-Ping Ruan, Tao Tian, Xuan Liang & Yu Yao. (2022) The Efficacy and Safety of Anlotinib in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study. Cancer Management and Research 14, pages 2273-2287.
Read now
Read now
Song Zhang, Xin Wang, Hao Gu & Jun-Qi Liu. (2022) Feasibility and Safety of Anlotinib Monotherapy for Patients with Previously Treated Advanced Esophageal Squamous Cell Carcinoma: A Real-World Exploratory Study. Cancer Management and Research 14, pages 1715-1727.
Read now
Read now
Hong-Tao Jiang, Wei Li, Biao Zhang, Qiang Gong & Hai-Ling Qie. (2021) Efficacy and Safety of Anlotinib Monotherapy as Third-Line Therapy for Elderly Patients with Non-Small Cell Lung Cancer: A Real-World Exploratory Study. International Journal of General Medicine 14, pages 7625-7637.
Read now
Read now
Rui-Tao Wang, Yang Zhao, An-Lei Wang, Yu-Ting Wang, Zhong-Ping Yin & Kai Chen. (2021) Efficacy and Safety of Regorafenib Monotherapy among Patients with Previously Treated Metastatic Colorectal Cancer in a Chinese Population: A Real-World Exploratory Study. International Journal of General Medicine 14, pages 5363-5373.
Read now
Read now
Articles from other publishers (14)
Yuan Wu, Xuefeng Zhou, Weiqing Zhao, Qiong Wang, Zhengxiang Han, Lifeng Wang, Wenjie Zhou, Tong Zhou, Haizhu Song, Yong Chen, Kaihua Yang, Lin Shi, Banzhou Pan, Renhong Guo, Guoren Zhou, Feng Jiang, Jifeng Feng & Bo Shen. (2023) Therapeutic effectiveness of anlotinib combined with etoposide in extensive-stage small-cell lung cancer: a single-arm, phase II trial. Investigational New Drugs 41:6, pages 825-833.
Crossref
Crossref
Jintong Na, Xiyu Liu, Xinjun Sun, Dianfa Fan, Zhangbo Qian, Min Yao, Lina Pan, Ziqing He, Qiaoqiao Liu, Zhen Shen, Rong Jiao, Xia Lin, Lu Gan, Guiyin Li & Liping Zhong. (2023) Anlotinib: A Novel Molecular-Targeted Drug for Tumours. Journal of Biomedical Nanotechnology 19:6, pages 897-918.
Crossref
Crossref
Huilin Xu, Dedong Cao, Fangfang Jie, Anbing He & Wei Ge. (2022) The efficacy and safety of anlotinib for subsequent line treatment of small cell lung cancer: a systematic review and meta-analysis. Tumori Journal 109:2, pages 203-214.
Crossref
Crossref
Wenxian Wang, Lan Shao, Yibing Xu, Zhengbo Song, Guangyuan Lou, Yiping Zhang & Ming Chen. (2022) Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Tian Chen, Mengqiu Tang, Xiaoyu Xu, Gaofeng Liang, Zhenfei Xiang, Yi Lu, Chen Wang & Weiyu Shen. (2022) Inflammation‐based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy. Journal of Clinical Laboratory Analysis 36:12.
Crossref
Crossref
Jie Liang, Xiaojiao Guan, Guangyao Bao, Yao Yao & Xinwen Zhong. (2022) Molecular subtyping of small cell lung cancer. Seminars in Cancer Biology 86, pages 450-462.
Crossref
Crossref
Hao-Ran Zheng, Ai-Min Jiang, Huan Gao, Na Liu, Xiao-Qiang Zheng, Xiao Fu, Zhi-Ping Ruan, Tao Tian, Xuan Liang & Yu Yao. (2022) The efficacy and safety of anlotinib combined with platinum-etoposide chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A Chinese multicenter real-world study. Frontiers in Oncology 12.
Crossref
Crossref
Xiao-Ping Li, Wei-Dong Zhang, Ming-Jiang Li, Juan Wang, Jie Lian & Hong-Gang Zhou. (2022) Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study. Journal of Oncology 2022, pages 1-10.
Crossref
Crossref
Xinhang Xia, Wenhu Pi, Yanli Lan, Xiaomai Wu, Dongqing Lv, Yinnan Meng, Haihua Yang & Wei Wang. (2022) Synergistic Antitumor Effects of Anlotinib Combined with Oral 5-Fluorouracil/S-1 via Inhibiting Src/AKT Signaling Pathway in Small-Cell Lung Cancer. Analytical Cellular Pathology 2022, pages 1-9.
Crossref
Crossref
Chang Liu, Jiatao Liao, Xianghua Wu, Xinmin Zhao, Si Sun, Huijie Wang, Zhihuang Hu, Yao Zhang, Hui Yu & Jialei Wang. (2022)
A phase
II
study of anlotinib combined with etoposide and platinum‐based regimens in the first‐line treatment of extensive‐stage small cell lung cancer
. Thoracic Cancer 13:10, pages 1463-1470.
Crossref
Crossref
Bing Lv, Jing Chen & Xiao-Liang Liu. (2022) Anlotinib-Induced Hypertension: Current Concepts and Future Prospects. Current Pharmaceutical Design 28:3, pages 216-224.
Crossref
Crossref
Yonghui Li, Zhenqing Sun, Wei Sun, Haibo Wang & Jinchi Zu. (2022) Effectiveness and Safety of Anlotinib Monotherapy for Patients with Extensive-stage Small-Cell Lung Cancer Who Progressed to Chemotherapy: A Real-world Exploratory Study. Clinical Medicine Insights: Oncology 16, pages 117955492110671.
Crossref
Crossref
Yuying Gan, Pingli Liu & Tao Luo. (2021) Successful Treatment of an Elderly Patient With Combined Small Cell Lung Cancer Receiving Anlotinib: A Case Report. Frontiers in Oncology 11.
Crossref
Crossref
Agnese Montanino, Anna Manzo, Guido Carillio, Giuliano Palumbo, Giovanna Esposito, Vincenzo Sforza, Raffaele Costanzo, Claudia Sandomenico, Gerardo Botti, Maria C. Piccirillo, Priscilla Cascetta, Giacomo Pascarella, Carmine La Manna, Nicola Normanno & Alessandro Morabito. (2021) Angiogenesis Inhibitors in Small Cell Lung Cancer. Frontiers in Oncology 11.
Crossref
Crossref